CLINICAL ROLE -
Oncology Overview: Taking a Closer Look at Axicabtagene Ciloleucel
Axicabtagene ciloleucel (Yescarta) received accelerated FDA approval on March 5, 2021, for the treatment of adult patients with relapsed or refractory FL after 2 or more lines of systemic therapy.
Read More
Conjunctivitis 101
Conjunctivitis, commonly referred to as pink eye, involves inflammation of the outer layer of the eye and inside of the eyelid.